Price Watch™ provides price assessments for Paracetamol (Acetaminophen) across top trading regions:
Asia-Pacific
- Paracetamol (Acetaminophen) Pharma Grade (IP) (>99%) (Powder) Ex-Vadodara, India
- Paracetamol (Acetaminophen) Pharma Grade (IP) (>99%) (Powder) Ex-Ludhiana, India
- Paracetamol (Acetaminophen) Pharma Grade (IP) (>99%) (Powder) FOB Hyderabad ICD, India
- Paracetamol (Acetaminophen) Pharma Grade (IP) (>99%) (Powder) FOB Nhava Sheva Mumbai, India
- Paracetamol (Acetaminophen) Pharma Grade (IP) (>99%) (Powder) Ex-Hebei, China
- Paracetamol (Acetaminophen) Pharma Grade (IP) (>99%) (Powder) FOB Tianjin, China
- Paracetamol (Acetaminophen) Pharma Grade (IP) (>99%) (Powder) CIF Haiphong (China), Vietnam
North America
- Paracetamol (Acetaminophen) Pharma Grade (IP) (>99%) (Powder) CIF New York (India), USA
Europe
- Paracetamol (Acetaminophen) Pharma Grade (IP) (>99%) (Powder) CIF Valencia (India), Spain
South America
- Paracetamol (Acetaminophen) Pharma Grade (IP) (>99%) (Powder) CIF Santos, Brazil
Note: In assessments structured as CIF [Importing Port] (Exporting Country), the country mentioned in brackets indicates the primary origin of supply (exporting country), while the named port refers to the destination port in the importing country. Other Incoterms (FOB, FD, EXW, etc.) should be interpreted in accordance with standard international trade definitions
Paracetamol (Acetaminophen) Price Trend Q4 2025
In Q4 2025, the global Paracetamol (Acetaminophen) market remained under pressure, as prices in both China and India continued to soften amid ongoing oversupply and cautious downstream demand. Across the two regions, quarter-on-quarter price declines of roughly 2-4% were observed largely driven by high inventory levels, aggressive export pricing and subdued buying from formulation manufacturers.
Production levels stayed stable and the lack of upward movement in upstream costs further supported the downward price adjustment. Although routine pharmaceutical demand and selective restocking offered some support overall market sentiment remained cautious. Looking ahead, the outlook stayed subdued with any potential recovery dependent on a rebound in demand, supply-side discipline or changes in global trade competitiveness.
China: Paracetamol (Acetaminophen) Export Prices FOB Tianjin, China, Pharma Grade (USP) (>99%) (Powder)
In Q4 2025, Paracetamol (Acetaminophen) prices in China moved in the range of USD 2,650-2,720 per metric ton posting a quarter-on-quarter decline of 1.90%. While the rate of price erosion slowed compared with the previous quarter, underlying market conditions remained weak, largely due to persistent global oversupply and subdued export demand. Downstream buyers continued to adopt a cautious procurement approach, drawing down existing stocks and covering only near-term requirements. Production levels at major manufacturing units stayed stable, limiting any scope for supply tightening. In the absence of clear demand recovery signals, the market ended the quarter with a bearish to range-bound outlook.
India: Paracetamol (Acetaminophen) Domestically Traded prices in Ex-Vadodara, India, Pharma Grade (IP) (>99%) (Powder)
In Q4 2025, Paracetamol (Acetaminophen) prices in India continued to weaken, settling into a lower consolidated range of USD 2730-2770 per metric ton and recording a 4.18% quarter-on-quarter decline. The extended correction was driven by comfortable domestic supply, elevated carryover stocks, and subdued export demand in the face of intense global API competition. Production rates remained largely unchanged, sustaining pressure on the supply side, while buyers largely limited purchases to immediate requirements. Although pharmaceutical consumption remained steady, it was not strong enough to absorb excess volumes, leaving market sentiment bearish with little near-term upside in sight.

